Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311789743> ?p ?o ?g. }
- W4311789743 endingPage "2465" @default.
- W4311789743 startingPage "2465" @default.
- W4311789743 abstract "This study tested the hypothesis that intrarenal arterial transfusion of oxidized low-density lipoprotein (ox-LDL) jeopardized the residual renal function and kidney architecture in rat chronic kidney disease ((CKD), i.e., induced by 5/6 nephrectomy) that was reversed by rosuvastatin. Cell culture was categorized into A1 (NRK-52E cells), A2 (NRK-52E + TGF-β), A3 (NRK-52E + TGF-β + ox-LDL) and A4 (NRK-52E + TGF-β + ox-LD). The result of in vitro study showed that cell viability (at 24, 48 and 72 h), NRK-52E ox-LDL-uptake, protein expressions of epithelial–mesenchymal–transition (EMT) markers (i.e., p-Smad2/snail/α-SMA/FSP1) and cell migratory and wound healing capacities were significantly progressively increased from A1 to A4 (all p < 0.001). SD rats were categorized into group 1 (sham-operated control), group 2 (CKD), group 3 (CKD + ox-LDL/0.2 mg/rat at day 14 after CKD induction) and group 4 (CKD + ox-LDL-treated as group 3+ rosuvastatin/10 mg/kg/day by days 20 to 42 after CKD induction) and kidneys were harvested at day 42. The circulatory levels of BUN and creatinine, ratio of urine-protein to urine-creatinine and the protein expressions of the above-mentioned EMT, apoptotic (cleaved-caspase3/cleaved-PARP/mitochondrial-Bax) and oxidative-stress (NOX-1/NOX-2/oxidized-protein) markers were lowest in group 1, highest in group 3 and significantly higher in group 4 than in group 2 (all p < 0.0001). Histopathological findings demonstrated that the kidney injury score, fibrotic area and kidney injury molecule-1 (KIM-1) displayed an identical pattern, whereas the cellular expression of podocyte components (ZO-1/synaptopodin) exhibited an opposite pattern of EMT markers (all p < 0.0001). In conclusion, ox-LDL damaged the residual renal function and kidney ultrastructure in CKD mainly through augmenting oxidative stress, EMT and fibrosis that was remarkably reversed by rosuvastatin." @default.
- W4311789743 created "2022-12-28" @default.
- W4311789743 creator A5001141477 @default.
- W4311789743 creator A5001850751 @default.
- W4311789743 creator A5028066500 @default.
- W4311789743 creator A5038240477 @default.
- W4311789743 creator A5044602271 @default.
- W4311789743 creator A5065192787 @default.
- W4311789743 creator A5067953128 @default.
- W4311789743 creator A5089347771 @default.
- W4311789743 date "2022-12-15" @default.
- W4311789743 modified "2023-10-14" @default.
- W4311789743 title "Oxidized-LDL Deteriorated the Renal Residual Function and Parenchyma in CKD Rat through Upregulating Epithelial Mesenchymal Transition and Extracellular Matrix-Mediated Tubulointerstitial Fibrosis—Pharmacomodulation of Rosuvastatin" @default.
- W4311789743 cites W1497663772 @default.
- W4311789743 cites W1597938677 @default.
- W4311789743 cites W1760215417 @default.
- W4311789743 cites W1987979328 @default.
- W4311789743 cites W1994827331 @default.
- W4311789743 cites W2022386093 @default.
- W4311789743 cites W2033457930 @default.
- W4311789743 cites W2072933848 @default.
- W4311789743 cites W2088900587 @default.
- W4311789743 cites W2095253772 @default.
- W4311789743 cites W2119186330 @default.
- W4311789743 cites W2143779541 @default.
- W4311789743 cites W2148184356 @default.
- W4311789743 cites W2154589460 @default.
- W4311789743 cites W2160109224 @default.
- W4311789743 cites W2317298663 @default.
- W4311789743 cites W2321759894 @default.
- W4311789743 cites W2398159510 @default.
- W4311789743 cites W2489258233 @default.
- W4311789743 cites W2518810364 @default.
- W4311789743 cites W2576066242 @default.
- W4311789743 cites W2579804224 @default.
- W4311789743 cites W2599607157 @default.
- W4311789743 cites W2600850172 @default.
- W4311789743 cites W2621172390 @default.
- W4311789743 cites W2792424265 @default.
- W4311789743 cites W2885408945 @default.
- W4311789743 cites W2901259619 @default.
- W4311789743 cites W2944963455 @default.
- W4311789743 cites W2967279669 @default.
- W4311789743 cites W2988427963 @default.
- W4311789743 cites W3005421091 @default.
- W4311789743 cites W3005681359 @default.
- W4311789743 cites W3021342806 @default.
- W4311789743 cites W3091546799 @default.
- W4311789743 cites W3091968197 @default.
- W4311789743 cites W3092213565 @default.
- W4311789743 cites W3137230464 @default.
- W4311789743 cites W3157731480 @default.
- W4311789743 cites W3158802449 @default.
- W4311789743 cites W3163978157 @default.
- W4311789743 cites W3207882511 @default.
- W4311789743 cites W4200550403 @default.
- W4311789743 cites W4229020262 @default.
- W4311789743 cites W4303579169 @default.
- W4311789743 doi "https://doi.org/10.3390/antiox11122465" @default.
- W4311789743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36552673" @default.
- W4311789743 hasPublicationYear "2022" @default.
- W4311789743 type Work @default.
- W4311789743 citedByCount "0" @default.
- W4311789743 crossrefType "journal-article" @default.
- W4311789743 hasAuthorship W4311789743A5001141477 @default.
- W4311789743 hasAuthorship W4311789743A5001850751 @default.
- W4311789743 hasAuthorship W4311789743A5028066500 @default.
- W4311789743 hasAuthorship W4311789743A5038240477 @default.
- W4311789743 hasAuthorship W4311789743A5044602271 @default.
- W4311789743 hasAuthorship W4311789743A5065192787 @default.
- W4311789743 hasAuthorship W4311789743A5067953128 @default.
- W4311789743 hasAuthorship W4311789743A5089347771 @default.
- W4311789743 hasBestOaLocation W43117897431 @default.
- W4311789743 hasConcept C121608353 @default.
- W4311789743 hasConcept C126322002 @default.
- W4311789743 hasConcept C126894567 @default.
- W4311789743 hasConcept C134018914 @default.
- W4311789743 hasConcept C159641895 @default.
- W4311789743 hasConcept C185592680 @default.
- W4311789743 hasConcept C2777390665 @default.
- W4311789743 hasConcept C2778653478 @default.
- W4311789743 hasConcept C2779013556 @default.
- W4311789743 hasConcept C2779561371 @default.
- W4311789743 hasConcept C2780091579 @default.
- W4311789743 hasConcept C2780306776 @default.
- W4311789743 hasConcept C2780499067 @default.
- W4311789743 hasConcept C2780559512 @default.
- W4311789743 hasConcept C71924100 @default.
- W4311789743 hasConcept C76419328 @default.
- W4311789743 hasConceptScore W4311789743C121608353 @default.
- W4311789743 hasConceptScore W4311789743C126322002 @default.
- W4311789743 hasConceptScore W4311789743C126894567 @default.
- W4311789743 hasConceptScore W4311789743C134018914 @default.
- W4311789743 hasConceptScore W4311789743C159641895 @default.
- W4311789743 hasConceptScore W4311789743C185592680 @default.
- W4311789743 hasConceptScore W4311789743C2777390665 @default.
- W4311789743 hasConceptScore W4311789743C2778653478 @default.
- W4311789743 hasConceptScore W4311789743C2779013556 @default.